Objective: Generalized peritonitis is fairly common with very high mortality of delayed diagnosis and treatment of infectious condition. In this study, we aimed to determine the effectiveness of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) and C-reactive protein (CRP) levels in peritonitis severity.Methods: This study was planned prospective and randomized. Study consisted of three groups. Each group had 50 patients. Group 1, patients with generalize peritonitis ; Group 2,patients with non-abdominal inflammatory disease; Group 3, healthy individuals as a control group. The venous blood samples from patients in group 1 and 2 were collected to determine MDA, SOD, CAT and CRP levels at the operation day. The same procedures repeated postoperative first and third day. Blood samples were collected once from group 3.One-way Anova test was used to compare average of intergroup parametric variables. Repeated Anova test was used to compare intragroup parameters.Results: Demographic features and cause of laparatomy of all groups were evaluated. MDA values of group 1 in days 0, 1st and 3rd compared with group 2 and group 3 the MDA values of group 1 were higher than group 2 and 3 (p<0,0001). CAT values of group 1 in days 0, 1st and 3rd were lower than group 2 and group 3 (p<0,0001). SOD values of group 1 and 2 in day 0 were lower than group 3 (p<0,0001). CRP values of group 1 in days 0,1st and 3rd were higher than group 2 (p<0,0001).

No abstract

Background: Mastalgia defines pain that is located in or felt in the breast area. Pain can be a symptom in many psychiatric disorders. Therefore, considering the psychiatric disorders in the evaluation of patients with mastalgia is of great importance in terms of treatment success and pain control Aims and Objective: In this study, we aimed to identify the psychiatric diagnoses that may be involved in the etiology of mastalgia and to retrospectively determine the frequency of patients who may need psychiatric treatment among the treatment options that can be used in patients with mastalgia Materials and Methods: We included patients who presented with breast pain between August 2017 and August 2018 and had normal results of radiological imaging studies. The archive system of the hospital was screened for the presence of any psychiatric admission before the diagnosis and previous psychiatric diagnoses, if any, were recorded Results: There were 1124 patients with mastalgia included in our study. Screening of psychiatric comorbidities recorded in the archive system revealed the presence of psychiatric admissions in 19.04% (n = 214) of the patients. Student's t-independent test showed a statistically significant difference between the mean age of mastalgia patients with and without psychiatric comorbidity Conclusion: In our study, we demonstrated the presence of anxiety disorder as psychiatric comorbidity in a high percentage of patients (43.9%), which was consistent with the rates reported in the literature of somatic symptoms, which are associated with anxiety disorder.

No abstract